Shire

Takhzyro is a preventive treatment for the genetic condition hereditary angioedema

Experimental drug led to ‘significantly fewer’ attacks of life-threatening genetic condition

Date set for extraordinary general meeting to secure shareholder backing for acquisition

Japanese pharmaceutical company looking to cut debt raised to fund the deal

Sale proceeds are expected to enable pharma giant to further reduce its leverage

Kingspan was standout performer of the day, rising 9.5 per cent following strong H1 results

Site in Kildare town made more than four times its guide price when sold in early 2017

CloudRanger is an enterprise back-up and disaster recovery platform for AWS

European shares extend recovery as dealmaking takes centre stage

Stem offers many career paths to graduates but what sets it apart from other areas of study?

New buyers are finding they get a lot more bang for their buck in this area

Market report: Dealmaking dominates activity in UK stocks with gains for Shire and Virgin Money

CRH bucks trend as buy-back plan announced

Acquisition would be largest ever outbound deal by Japanese company

Japanese drugmaker revises $60bn bid for biotechnology company

Reports had suggested pharma company would rival Takeda’s $60bn offer

Takeda Pharmaceutical has tabled $60 billion offer

Shire still hasn’t received a formal approach or offer from Takeda

C&C surges after purchase of Matthew Clark Bibendum, but UK investors play it safe

Doubts arise over how Japanese firm would pay for such deal given both groups’ debts

Fall of 7.5 per cent shaves more than $3 billion off Japanese pharma firm’s value

Market report: Amazon fell more than 5 per cent after reports that president Trump was looking to target the company by changing its tax treatment

Any deal would likely bid Irish rare disease specialist at close to €57bn

Irish domiciled company to get ‘customised training programmes’ from universities

Pfizer raises average wholesale price of 148 drugs by 6-13.5 per cent

Little change in global stock markets as US tax reform bill reaches the finish line

Ryanair, PaddyPower Betfair and PTSB singled out for not disclosing carbon footprint

Dublin market underperforms, with Paddy Power, Glanbia and CRH all lower

The pharma company upgrades guidance after strong first half

Iseq closes lower with BoI and Permanent TSB losing out as investors flock to AIB

Food group Aryzta slumps 9% after reporting flat revenues

Firm planning to create 150 new jobs in State reports product sales up 110% to $3.4bn

Last year the company announced a $400m investment in the Republic

Seen and Heard: NUI Maynooth to spend €300 million redeveloping campus

Drug companies rank lower overall for innovation and reputation in worldwide report

Iseq falls 0.8% as Paddy Power Betfair confirms a slowdown in online gaming

Tullow Oil up 0.65% in Dublin following announcement Aidan Heavey was to step down

Group did not admit wrongdoing in case over tactics used to boost Dermagraft sales

Shares in Fyffes surge almost 49% after news Sumitomo is to acquire the fruit distributor

Dublin-headquartered pharma giant is creating 400 jobs as part of the investment